Expressive RFID data access policies for the Pharmaceuticals supply chain

Pardal, Miguel L.; Harrison, Mark; Marques, Jorge S.

doi:10.1109/rfid.2013.6548155

Cited by 3 publications

(6 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…PSCs are affected by counterfeiting and theft issues, which not only compromise the profits and reputations of manufacturers, wholesalers, pharmacies, and hospitals, but also compromise public health and consumer safety [18,19]. In this context, traceability plays a central role, particularly in supply chains where multiple parties are involved and in which rigorous criteria must be fulfilled to lead to a successful outcome [20,21,22].…”

Section: Pharmaceutical Supply Chainmentioning

confidence: 99%

Critical Success Factors of a Drug Traceability System for Creating Value in a Pharmaceutical Supply Chain (PSC)

Silva

Mattos

2019

IJERPH

View full text Add to dashboard Cite

The general objective of this study was to identify and prioritize the critical success factors required for the adoption of a system to create value for pharmaceutical supply chain stakeholders, and the pharmaceutical supply network as a whole, by using a multi-perspective framework that combines elements of the technology–organization–environment (TOE) contexts for enterprises. The methodology is based on a literature review and expert interviews following the analytic hierarchy process (AHP). This paper identifies and prioritizes 18 critical success factors from three categories: technological, organizational, and environmental. From a practical point of view, this research contributes to the literature by providing expert insight on the topic of drug traceability, especially in terms of how possible values can be captured by companies.

show abstract

Section: Pharmaceutical Supply Chainmentioning

confidence: 99%

Critical Success Factors of a Drug Traceability System for Creating Value in a Pharmaceutical Supply Chain (PSC)

Silva

Mattos

2019

IJERPH

View full text Add to dashboard Cite

show abstract

“…De hecho, Estados Unidos cuentan con un ambicioso proyecto llamado Electronic Pedigree (e-Pedrigree -eP-) [33], correspondiente a una legislación vigente en varios estados y la definición de un estándar avalado por la GS1 5 . Electronic Pedigree básicamente es un documento electrónico en formato XML que provee un historial acerca de la "vida" de un medicamento y declara que el origen del mismo es conocido, por tanto, se encuentra apto para su circulación, comercialización y consumo por parte de los clientes [34].…”

Section: Rfid Dentro De La Industria Farmacéuticaunclassified

“…En este registro se encuentran las fechas y los nombres de quienes manipulan el medicamento. Otra iniciativa importante es la que lidera la Unión Europea [33,35] PoD (Pointof-Dispense Authentication).…”

Section: Rfid Dentro De La Industria Farmacéuticaunclassified

“…La integración de la tecnología RFID en cada uno de los procesos mencionados anteriormente en la industria farmacéutica conlleva a nuevos retos en el momento de la implementación como lo es un cambio en la infraestructura, inversión en nuevos equipos lectores, middleware, etiquetas y demás artefactos necesarios para una correcta implementación. No obstante, se debe tener en cuenta el final de las etiquetas, la reutilización de las mismas, el reciclaje que se les puede llegar a dar enmarcado dentro de un modelo de sostenibilidad [33].…”

Section: Distribución De Medicamentosunclassified

See 1 more Smart Citation

Análisis de una implementación RFID dentro de la industria farmacéutica

2017

View full text Add to dashboard Cite

Resumen ¿Cuál o cuáles serían los mecanismos para apoyar a la industria farmacéutica en cuanto a la mejora de sus procesos con herramientas tecnológicas para combatir los medicamentos espurios? Ante este planteamiento se enfrentan las sociedades a nivel mundial, quienes ven con preocupación cómo el mercado de medicamentos falsificados aumenta en una proporción similar a las muertes por su consumo. Este escenario plantea grandes retos para los gobiernos quienes deberán tomar decisiones que intenten detener la fabricación, expendio y consumo de medicamentos espurios, de etiquetado engañoso o de imitación. Existen numerosos riesgos dentro la industria farmacéutica, tales como las imitaciones, procesos incorrectos de fabricación y condiciones inapropiadas de transporte y almacenamiento, que ocasionan riesgos a los diferentes actores como los fabricantes, distribuidores y clientes, de tal manera que pueden llegar a tener pérdidas económicas o afectaciones en la salud. Así, en este documento se pretende mostrar cómo algunas implementaciones que utilizan tecnologías con radiofrecuencia en la industria farmacéutica, ayudan a mitigar la posibilidad de riesgo en las diferentes etapas a lo largo de la cadena de producción y suministro de medicamentos, buscando mejorar la calidad en los procesos y la seguridad en los fármacos. Abstract What would be the mechanisms to support the pharmaceutical industry in improving its processes with technological tools to combat spurious drugs? Faced with this approach are the societies worldwide, who see with concern how the market for counterfeit medicines increases in a proportion similar to the deaths by their consumption. This scenario poses great challenges for governments who must make decisions that seek to stop the manufacture, sale and consumption of spurious medicines, misleading or imitation labeling. There are numerous risks within the pharmaceutical industry, such as imitations, incorrect manufacturing processes and inappropriate transport and storage conditions, which pose risks to different actors such as manufacturers, distributors and customers, in such a way that they can lead to losses Economic or health effects. Thus, this document aims to show how some implementations that use radiofrequency technologies in the pharmaceutical industry, help mitigate the possibility of risk at different stages along the production and supply chain of medicines, seeking to improve quality in Processes and drug safety. Palabras Clave IntroducciónEl presente artículo introduce al lector en la Tecnología de Identificación por Radiofrecuencia -(en adelante RFID) -, para ello se toman como ejemplos algunos casos deéxito en su implementación y uso dentro la industria farmacéutica, en la que se puede evidenciar mejoras en los procesos de distribución [1,2], mitigando diferentes vulnerabilidades por la puesta en marcha de sistemas con tecnología RFID [3].En dicha industria se ponen en funcionamiento diferentes mecanismos de monitoreo que ayudan a hacer un control a los medicamentos en las etap...

show abstract

“…In the agri-food sector, traceability refers to the capacity to identify and trace the history and ingredients of a product through the food supply chain (Costa et al 2013). In the pharmaceutical sector, traceability refers to the capacity to identify and track pharmaceutical products from labs to consumers (Pardal et al 2013). In the forest sector, traceability refers to the capacity to identify, certify the origin of wood and track products through the forest supply chain (Lins Da Silva, Corre, and Najm 2010;Häkli et al 2013).…”

Section: The Traceability Conceptmentioning

confidence: 99%

Review, typology and evaluation of traceability technologies: case of the French forest supply chain

Saikouk

Spalanzani

2016

Supply Chain Forum: An International Journal

View full text Add to dashboard Cite

The use of supply chain management and traceability systems are increasingly important in the forest industry. The adoption of traceability technologies and labelling procedures has become key element to promote the principles of sustainable development in the French forest. This later suffers from a misuse of resources, which negatively impacts the forest ecosystem including the economic competitiveness and biodiversity. However, opting for a suitable technology that resists to the forest environment and does not require a major organisational change is a major challenge for the entire forest supply chain's partners. For this reason, throughout this paper, we suggest a multi-criterion assessment grid to better choose an effective and efficient traceability system, which might include one or more technologies. Thus, our main objective is to review, typologise and evaluate six technologies that could be used in the forest supply chain.

show abstract

Expressive RFID data access policies for the Pharmaceuticals supply chain

Cited by 3 publications

References 14 publications

Critical Success Factors of a Drug Traceability System for Creating Value in a Pharmaceutical Supply Chain (PSC)

Critical Success Factors of a Drug Traceability System for Creating Value in a Pharmaceutical Supply Chain (PSC)

Análisis de una implementación RFID dentro de la industria farmacéutica

Review, typology and evaluation of traceability technologies: case of the French forest supply chain

Contact Info

Product

Resources

About